🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This clinical trial aimed to gather safety and immunogenicity data in COVID...
Status
Completed
Location
The Affiliated Hospital of Yunnan University
Start Date
2023-05-08
Trial ID
NCT05907044
To determine whether providing a recombinant booster COVID-19 vaccine impro...
Status
Completed
Location
UW School of Medicine and Public Health
Start Date
2023-11-20
Trial ID
NCT06027229
Treatments Being Tested
This was an exploratory Phase I, randomized, observer-blind, active-control...
Status
Completed
Location
Alliance for Multispecialty Research, LLC
Start Date
2022-11-08
Trial ID
NCT05541861
This is a Phase 2/3, randomized, double-blind study to evaluate the safety ...
Status
Completed
Location
ARS-Birmingham CRU
Start Date
2023-10-16
Trial ID
NCT05925127
The primary objective of the study is to determine the relative efficacy of...
Status
Active Not Recruiting
Location
Pinnacle Research Group
Start Date
2024-10-08
Trial ID
NCT06672055
Treatments Being Tested
The primary objective of this study is to determine the vaccine effectivene...
Status
Completed
Location
Kaiser Permanente Southern California
Start Date
2021-05-15
Trial ID
NCT04848584
The purpose of this study is to assess the immunogenicity and safety of SCB...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-10
Trial ID
NCT06567457
This trial aims to measure the humoral and adaptive immune response in pati...
Status
Terminated
Location
Institut Jules Bordet
Start Date
2021-12-01
Trial ID
NCT05075538
This is a Phase 2/3 open-label study to evaluate the safety and immunogenic...
Status
Completed
Location
AMR
Start Date
2023-09-07
Trial ID
NCT05975060
Treatments Being Tested
The goal of this observational study is to analyze binding antibody levels ...
Status
Completed
Location
Science37
Start Date
2023-03-08
Trial ID
NCT05765578